Zymeworks, Inc. (ZYME)
23.17
+0.07
(+0.30%)
USD |
NASDAQ |
Jan 09, 16:00
23.18
+0.01
(+0.04%)
After-Hours: 20:00
Zymeworks Research and Development Expense (Annual): 134.62M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Jazz Pharmaceuticals Plc | 884.00M |
| Johnson & Johnson | 17.26B |
| Regeneron Pharmaceuticals, Inc. | 4.624B |
| Vertex Pharmaceuticals, Inc. | 3.630B |
| CorMedix, Inc. | 3.942M |